Sickle Cell Transplant Advocacy & Research Alliance (STAR)

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant	Bone Marrow Failure Disorders, Congenital Bone Marrow Failure Syndromes, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA repair disease, Fanconi anemia, Hemic and Lymphatic Diseases, Nutritional and Metabolic Diseases, anemia, aplastic anemia, bone marrow disorder, familial hemolytic anemia, graft versus host disease, hematologic disorder, hemolytic anemia, hereditary disease, immune system disorder, inherited aplastic anemia, inherited hemoglobinopathy, metabolic disease, sickle cell disease, thalassemia	Active, not recruiting	Phase 2	2026-02-25		NCT03924401

Clinical trials